Abstract
Despite advances in promoting axonal regeneration after acute spinal cord injury (SCI), elicitation of bridging axon regeneration after chronic SCI remains a formidable challenge. We report that combinatorial therapies administered 6 weeks, and as long as 15 months, after SCI promote axonal regeneration into and beyond a midcervical lesion site. Provision of peripheral nerve conditioning lesions, grafts of marrow stromal cells, and establishment of NT-3 gradients supports bridging regeneration. Controls receiving partial components of the full combination fail to exhibit bridging. Notably, intraneuronal molecular mechanisms recruited by delayed therapies mirror those of acute injury, including activation of transcriptional activators and regeneration-associated genes. Collectively, these findings provide evidence that regeneration is achievable at unprecedented postinjury time points.
MeSH Terms
Analysis of Variance
Animals
Axons/drug effects,physiology
Bone Marrow Transplantation/physiology
Cells, Cultured
Cholera Toxin
Disease Models, Animal
Female
GAP-43 Protein/metabolism
Ganglia, Spinal/cytology
Gene Expression Profiling/methods
Glial Fibrillary Acidic Protein/metabolism
Green Fluorescent Proteins/genetics,metabolism
Nerve Regeneration/drug effects,physiology
Nerve Tissue Proteins/metabolism
Neurotrophin 3/therapeutic use
Oligonucleotide Array Sequence Analysis/methods
Proto-Oncogene Proteins c-jun/metabolism
Rats
Rats, Inbred F344
Sensory Receptor Cells/drug effects,metabolism
Spinal Cord Injuries/pathology,physiopathology,therapy
Time Factors
Chemicals
GAP-43 Protein
Glial Fibrillary Acidic Protein
Nerve Tissue Proteins
Neurotrophin 3
Proto-Oncogene Proteins c-jun
Green Fluorescent Proteins
Cholera Toxin
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Kadoya Ken
Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, USA.
Tsukada Shingo
Lu Paul
Coppola Giovanni
Geschwind Dan
Filbin Marie T
Blesch Armin
Tuszynski Mark H
References (23)
23 references, click to expand
-
Repair of chronic spinal cord injury.
Exp Neurol. 2003 Aug;182(2):247-60
PMID: 12895437
-
The role of extracellular matrix in CNS regeneration.
Curr Opin Neurobiol. 2007 Feb;17(1):120-7
PMID: 17223033
-
Bridging areas of injury in the spinal cord.
Neuroscientist. 2001 Aug;7(4):325-39
PMID: 11488398
-
cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury.
Nat Med. 2004 Jun;10(6):610-6
PMID: 15156204
-
Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury.
Neuron. 1999 May;23(1):83-91
PMID: 10402195
-
Neurotrophin-3 gradients established by lentiviral gene delivery promote short-distance axonal bridging beyond cellular grafts in the injured spinal cord.
J Neurosci. 2006 Sep 20;26(38):9713-21
PMID: 16988042
-
A transcription-dependent switch controls competence of adult neurons for distinct modes of axon growth.
J Neurosci. 1997 Jan 15;17(2):646-58
PMID: 8987787
-
Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation.
Neuron. 2002 Jun 13;34(6):885-93
PMID: 12086637
-
Spinal axon regeneration induced by elevation of cyclic AMP.
Neuron. 2002 Jun 13;34(6):895-903
PMID: 12086638
-
NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection.
Exp Neurol. 2003 May;181(1):47-56
PMID: 12710933
-
Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts.
Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3908-13
PMID: 9520466
-
Conditioning injury-induced spinal axon regeneration requires signal transducer and activator of transcription 3 activation.
J Neurosci. 2005 Feb 16;25(7):1645-53
PMID: 15716400
-
Combining an autologous peripheral nervous system "bridge" and matrix modification by chondroitinase allows robust, functional regeneration beyond a hemisection lesion of the adult rat spinal cord.
J Neurosci. 2006 Jul 12;26(28):7405-15
PMID: 16837588
-
Inflammatory-mediated injury and repair in the traumatically injured spinal cord.
Curr Pharm Des. 2005;11(10):1223-36
PMID: 15853679
-
Overcoming inhibition in the damaged spinal cord.
J Neurotrauma. 2006 Mar-Apr;23(3-4):371-83
PMID: 16629623
-
Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury.
J Neurosci. 2004 Jul 14;24(28):6402-9
PMID: 15254096
-
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS.
Nat Rev Neurosci. 2003 Sep;4(9):703-13
PMID: 12951563
-
Survival and regeneration of rubrospinal neurons 1 year after spinal cord injury.
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3246-51
PMID: 11867727
-
Axonal regeneration and functional recovery after complete spinal cord transection in rats by delayed treatment with transplants and neurotrophins.
J Neurosci. 2001 Dec 1;21(23):9334-44
PMID: 11717367
-
Fibroblasts genetically modified to produce BDNF support regrowth of chronically injured serotonergic axons.
Neurorehabil Neural Repair. 2000;14(4):311-7
PMID: 11402881
-
The AP-1 transcription factor c-Jun is required for efficient axonal regeneration.
Neuron. 2004 Jul 8;43(1):57-67
PMID: 15233917
-
Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury.
J Physiol. 2001 May 15;533(Pt 1):83-9
PMID: 11351016
-
Retrograde degeneration of corticospinal axons following transection of the spinal cord in rats. A quantitative study with anterogradely transported horseradish peroxidase.
J Neurosurg. 1988 Jan;68(1):124-8
PMID: 3335897